User research SaaS M&A has a classification problem. Acquirers are evaluating every UX research platform against the same metrics — ARR, NRR, seat growth, and the obligatory AI roadmap slide. But a new survey of nearly 500 researchers, designers, and product professionals reveals that the category has quietly bifurcated into two fundamentally different types of assets. One is commoditizing fast. The other is becoming more defensible by the quarter. Most deal teams can’t tell them apart.
The Maze Future of User Research Report 2026 — subtitled From Influence to Infrastructure — is not primarily an M&A document. It is a practitioner survey designed for research teams. But read through a deal-making lens, it documents a category transformation with direct implications for how research tool companies should be valued, positioned, and diligenced. The firms that understand this shift will make better acquisitions and better exits. The firms that don’t will discover it at close, or worse, post-close.
The Bifurcation Nobody Is Pricing
The report’s most important finding isn’t the headline AI adoption number — though it is striking. Nearly 2 in 3 researchers (69%) now use AI in their workflows, up 19 percentage points in a single year. Transcription, synthesis, data analysis, and even question generation have moved from differentiated product features to baseline expectations.
That is not a growth opportunity for research tool vendors. That is a compression signal.
When 76% of researchers use AI to analyze data and 57% use it for transcription, the products built primarily to do those things are no longer defensible on capability alone. The race to the bottom in execution-layer tooling — speed, throughput, automation rate — is being run by every vendor simultaneously, and the competitive advantage window on those features is measured in months, not years.
But the report also documents a second, countervailing trend that runs in the opposite direction. Research’s strategic importance has exploded. In 2025, only 8% of organizations considered research essential to all levels of business strategy and operations. In 2026, that number nearly tripled to 22%. At the same time, 41% now report that research informs both product and broader strategic business decisions — up from 37% the year prior.
| The Maze Data in One SentenceResearch execution is commoditizing at the exact moment research infrastructure is becoming strategically irreplaceable. The products enabling one are worth less than they were twelve months ago. The products enabling the other are worth more. |
What Makes a Tool an Execution Asset
Execution-layer research tools do the heavy lifting of research operations: they recruit participants, automate transcription, generate synthesis, and help teams move faster. These are real problems. The products solving them are real products with real revenue. But the competitive dynamics are working against them.
Consider what the Maze data shows about AI usage patterns in research:
- 76% use AI to analyze research data
- 57% use AI for transcription
- 56% use AI to plan and draft studies
- 55% use AI to generate research questions
Every one of those use cases is currently being solved — or will soon be solved — by general-purpose AI platforms that research tool vendors do not control. When OpenAI, Anthropic, or any well-funded vertical AI player decides to ship a research synthesis module, the moat around transcription-and-synthesis disappears overnight. We have written about this exact dynamic in our analysis of VC rejection signals in AI SaaS: when a well-funded AI-native team can replicate your core functionality in 6–9 months, you do not have a durable moat, and your acquisition price should reflect that reality.
The execution tool vendors that will survive and command premium exits are those that have moved up the stack before commoditization catches them. The ones that haven’t face a straightforward devaluation trajectory.
What Makes a Platform a Research Infrastructure Asset
Infrastructure is a word that gets overused in SaaS M&A positioning. In this context, it has a specific meaning: a research platform functions as infrastructure when removing it would cause not operational disruption, but organizational amnesia.
The Maze report describes what leading teams are actually building: systems of continuous learning that make insight accessible, repeatable, and actionable across the business. They are centralizing knowledge so teams start with what is already known. They are embedding research into sprint planning, roadmap reviews, and strategy discussions so insights shape decisions before they are finalized.
These are not workflow features. They are organizational change management functions encoded in software. And the report documents something critical about what makes them valuable: they do not derive their strategic importance from AI features.
When researchers were asked what most increases executive trust in their work, the answers were revealing:
- Clear business metrics and outcomes: 68%
- Strong storytelling and narratives: 57%
- Direct exposure to customers: 48%
- AI-supported analysis: just 17%
AI features, at 17%, barely register on the executive trust scale. Business outcomes and the ability to translate insight into narrative — those are what earn and hold organizational authority. A research platform that helps researchers do those things is not easily replaced. A platform that only makes research faster is competing on a dimension that AI is flattening.
| Infrastructure Diagnostic QuestionsA research platform is functioning as infrastructure — not just tooling — when you can answer yes to most of these:Does the platform store accumulated insights in a searchable, queryable repository that the whole organization accesses?Is research output embedded in the cadences that govern product and business decisions (e.g., linked in sprint planning docs, roadmap reviews, strategy decks)?Does the platform generate traceable insight provenance — so stakeholders can audit how a conclusion was reached?Would losing the platform require rebuilding organizational memory, not just replacing a workflow?Is the platform used by functions beyond the core research team (product, engineering, marketing, sales, executives)? |
The Demand Signal M&A Buyers Are Underweighting
There is a third dynamic in the Maze data that compounds the infrastructure story: demand for research is massively outpacing the organizational capacity to deliver it. In 2025, 55% of product professionals reported increased demand for research. In 2026, that number climbed to 66%. The mandate has grown. Resources haven’t.
This is not a market saturation problem. It is a capacity crisis — and capacity crises are consistently underpriced in M&A diligence because they don’t show up in product usage metrics or ARR growth. What they reveal is the degree to which a product is becoming load-bearing infrastructure for an organization that cannot function without it.
The report is explicit about what happens when demand outpaces enablement: research spreads across non-specialist teams (55% of designers, 39% of product managers, and 35% of market researchers now conduct research), standardization collapses, insights live in silos, and organizations repeatedly rebuild work that already exists somewhere they can’t find it. One participant described the outcome clearly: “We often redo research because we don’t have a central place to store or find past studies.”
For M&A buyers, that fragmentation is not a sign of market failure. It is the purchase justification for the infrastructure platforms that solve it. The organizations experiencing this dynamic are motivated buyers — and the products that solve it hold pricing power.
This mirrors what we observed in our analysis of Q3 2025 enterprise SaaS M&A data: knowledge management systems saw deal value explode 546% quarter-over-quarter, driven by exactly this type of enterprise AI integration requirement. Research infrastructure platforms are the KMS of product and design — and they are following the same acquisition logic.
Research Has Claimed a Boardroom Seat — That Changes the M&A Calculus
One of the most striking data points in the Maze report is the dramatic shift in research’s organizational authority. The share of organizations where research insights are considered essential to all levels of business strategy and operations nearly tripled from 8% to 22% in a single year.
That is not the growth rate of a feature. That is the growth rate of a strategic function claiming organizational territory. And when a function claims that territory, the software enabling it acquires a new kind of stickiness — political stickiness.
The report documents how this manifests in practice. Research is no longer conducted only by UX specialists. It is spreading company-wide: 55% of designers, 39% of product managers, and even 23% of marketers now conduct research. Sales adoption more than doubled. Executive team engagement increased 29% to 31%.
For M&A buyers, elevated organizational authority creates a compounding dynamic. The more deeply research is embedded in business decisions, the harder the platform enabling it is to displace. The platform becomes less like a productivity tool and more like organizational infrastructure. Switching costs — already high in enterprise software — become existential: you are not just replacing a product, you are disrupting how the organization makes decisions.
This is not the story most user research tool vendors are telling buyers. Most pitch around seat count, AI features, and workflow automation. The companies with the best acquisition outcomes will be the ones that can demonstrate — with data — that their platform is load-bearing in their customers’ strategic decision cycles. As we noted in our analysis of the Agentforce market narrative, the due diligence question is not whether a company has integrated AI. It is whether that company owns a workflow. In user research SaaS, the equivalent question is whether the company owns a decision cycle.
What This Means For You
| For SaaS Founders: Know Which Side of the Bifurcation You’re OnThe most important question you need to answer before engaging with any buyer is simple: are you an execution tool or an infrastructure platform? The answer shapes your valuation, your buyer set, and your exit timeline.If you are primarily an execution tool — and many research platforms are — you are in a race against AI commoditization that has already started. Your exit window is shrinking, not expanding. The buyers most likely to pay a premium for execution tooling today are strategic acquirers who need to accelerate their AI research capabilities, not financial sponsors running hold-to-maturity models. Use this window before the next AI capability release makes it irrelevant.If your platform has legitimate infrastructure characteristics — centralized insight repositories, decision-embedded workflows, multi-functional adoption beyond the research team — you have a more patient M&A posture. Your story to buyers is not about features. It is about organizational dependency and switching cost asymmetry.Critical pre-exit preparation: document and quantify your infrastructure characteristics before any buyer conversation. How many non-research functions use your platform? How many strategic decisions were documented as informed by your platform last quarter? What would happen to the customer’s organizational knowledge if they migrated off your product? These are the due diligence answers that separate infrastructure pricing from execution pricing. |
| For PE/VC Investors: Rewrite Your Research Tool Diligence FrameworkThe standard research tool diligence checklist — ARR growth, NRR, seat penetration, AI roadmap — is not wrong. It is incomplete. The Maze 2026 data suggests you need an additional analytical layer: the execution/infrastructure classification.Execution tools should be evaluated on defensibility against AI commoditization — specifically the ability to replicate the core functionality with a well-funded AI-native build. If the answer is under 12 months at $5–10M in seed funding, you are underwriting a declining competitive position, and the valuation multiple should reflect it.Infrastructure platforms deserve a different multiple framework — one closer to how enterprise KMS and workflow automation assets are valued. The Maze data showing 22% of organizations now treat research as essential to all business strategy levels, up from 8%, signals that these platforms are in the early innings of enterprise adoption. That is a 2.75x expansion in total addressable organizational authority in a single year.Add one question to your diligence call: “What happens to your strategic planning process if you have to migrate off this platform?” The length and discomfort of the answer is your infrastructure assessment. |
| For Enterprise CTOs and CPOs: Build vs. Buy Has a New AnswerThe 2026 Maze data presents a direct challenge to enterprise technology buyers managing research function decisions. Two divergent pressures are colliding: research demand is at an all-time high (66% report YoY demand increase), and AI is commoditizing the execution functions that used to require specialized tools.The operational implication is counterintuitive: this is not the moment to build on execution-layer AI capabilities. It is the moment to invest in research infrastructure that AI cannot easily replace — specifically, the insight repository, standardization, and decision-embedding functions the Maze report identifies as the gap between “fast research” and “trusted research.”The report’s warning about speed without structure is directly relevant to your vendor evaluation criteria. Only 13% of organizations report no support resources for non-researchers — but fewer than half offer dedicated specialist support, structured training, or research libraries. That gap is where research quality breaks down as it scales. When evaluating vendors, prioritize platforms that make insight traceable, standardized, and organizationally embedded over platforms that primarily compete on AI-accelerated execution speed.Your AI productivity ROI story for research also needs recalibration. As we analyzed in our coverage of the AI productivity paradox, the 95% of organizations that see no measurable ROI from AI tools have one common failure mode: they invested in automation without first building the process clarity that makes automation valuable. In research, that means investing in infrastructure before layering AI execution on top of it. |
The Bottom Line
The Maze Future of User Research Report 2026 is not a market sizing document. It is a category bifurcation signal. The user research SaaS M&A market is pricing execution tools and infrastructure platforms as if they face the same competitive dynamics. They do not.
Execution tools face AI-driven commoditization. Their exit windows are open but narrowing. Infrastructure platforms — those that have become embedded in how organizations make strategic decisions — face an expansion in both organizational authority and switching costs. Their M&A story is one of deepening enterprise dependency, not feature competition.
The Maze data provides the diagnostic framework to tell them apart. A research platform that only makes research faster is an execution tool. A platform that makes insight systematic, traceable, and embedded in business decision cycles is infrastructure. In the current M&A market, those are two different valuations.Get this classification right before you sign the LOI. Review our M&A due diligence checklist and our analysis of AI SaaS investment trends and VC rejection signals for additional frameworks that apply directly to user research tool acquisitions.
